Cosmecca Korea Valuation Multiples

Cosmecca Korea is valued at $903M as of October 2026, a 1.8x revenue multiple. In the last 12 months, Cosmecca Korea revenue was $598M and Cosmecca Korea EBITDA was $95M.

Cosmecca Korea Overview

About Cosmecca Korea

Cosmecca Korea Co Ltd is engaged in research, development, and production of cosmetics. It offers various products including skincare, makeup products, and functional products. The skincare products consist of Cream, Essence, Cleansers, Korean herbal products, Exfoliators, and mask sheets. Its functional products comprise of skincare products with specific functions such as UV blocking, brightening, and wrinkle care. The Makeup products range comprise of BB & CC cream, Skin cover balms, Makeup base, Foundation, Concealer, Lipstick, Mascara, and Powders.


Founded

1999

HQ

South Korea

Employees

450

Financials (LTM)

Revenue: $598M
EBITDA: $95M

EV

$1.1B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cosmecca Korea Financials

Cosmecca Korea reported last 12-month revenue of $598M and EBITDA of $95M.

In the same LTM period, Cosmecca Korea generated $142M in gross profit, $95M in EBITDA, and $52M in net income.

Revenue (LTM)


Cosmecca Korea P&L

In the most recent fiscal year, Cosmecca Korea reported revenue of $479M and EBITDA of $73M.

Cosmecca Korea is profitable as of last fiscal year, with gross margin of 25%, EBITDA margin of 15%, and net margin of 7%.

See analyst estimates for Cosmecca Korea
LTMLast FY202320242025202620272028
Revenue$598M$479M$350M$390M$479M
Gross Profit$142M$118M$80M$93M$118M
Gross Margin24%25%23%24%25%
EBITDA$95M$73M$50M$65M$73M
EBITDA Margin16%15%14%17%15%
EBIT Margin13%13%10%12%13%
Net Profit$52M$34M$17M$32M$34M
Net Margin9%7%5%8%7%
Net Debt-$74M---

Financial data powered by Morningstar, Inc.

Cosmecca Korea Stock Performance

Cosmecca Korea has current market cap of $903M, and enterprise value of $1.1B.

Market Cap Evolution


Cosmecca Korea's stock price is $84.58.

Cosmecca Korea share price increased by 0.7% in the last 30 days, and by 82.8% in the last year.

Cosmecca Korea has an EPS (earnings per share) of $3.18.

See more trading valuation data for Cosmecca Korea
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$1.1B$903M0.1%0.7%53.8%82.8%$3.18

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cosmecca Korea Valuation Multiples

Cosmecca Korea trades at 1.8x EV/Revenue multiple, and 11.1x EV/EBITDA.

See NTM and 2027E valuation multiples for Cosmecca Korea

EV / Revenue (LTM)


Cosmecca Korea Financial Valuation Multiples

As of October 19, 2026, Cosmecca Korea has market cap of $903M and EV of $1.1B.

Cosmecca Korea has a P/E ratio of 17.3x.

LTMLast FY202320242025202620272028
EV/Revenue1.8x2.2x3.0x2.7x2.2x
EV/EBITDA11.1x14.5x21.3x16.2x14.5x
EV/EBIT13.1x16.9x28.8x23.5x16.9x
EV/Gross Profit7.4x8.9x13.2x11.4x8.9x
P/E17.3x26.6x54.4x28.4x26.6x
EV/FCF31.6x(220.0x)61.0x69.4x(220.0x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cosmecca Korea Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cosmecca Korea Margins & Growth Rates

Cosmecca Korea grew revenue by 33% and EBITDA by 40% in the last fiscal year.

In the most recent fiscal year, Cosmecca Korea reported gross margin of 25%, EBITDA margin of 15%, and net margin of 7%.

See estimated margins and future growth rates for Cosmecca Korea

Cosmecca Korea Margins

Last FY202420252026202720282029
Gross Margin25%24%25%24%
EBITDA Margin15%17%15%16%
EBIT Margin13%12%13%14%
Net Margin7%8%7%9%
FCF Margin(1%)4%(1%)6%

Cosmecca Korea Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth33%11%23%33%
Gross Profit Growth28%16%27%28%
EBITDA Growth40%32%11%40%
EBIT Growth38%23%39%38%
Net Profit Growth67%92%7%67%
FCF Growth(959%)(12%)(132%)(959%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cosmecca Korea Operational KPIs

Cosmecca Korea's revenue per employee in the last FY averaged $1.1M, while opex per employee averaged $0.1M for the same period.

Cosmecca Korea's Rule of 40 is 49% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cosmecca Korea's Rule of X is 99% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cosmecca Korea
LTMLast FY202320242025202620272028
Rule of 4038%49%---
Bessemer Rule of X70%99%---
Revenue per Employee-$1.1M---
Opex per Employee-$0.1M---
S&M Expenses to Revenue-2%2%2%2%
G&A Expenses to Revenue-1%1%1%1%
R&D Expenses to Revenue2%3%3%3%3%
Opex to Revenue-12%12%12%12%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cosmecca Korea Competitors

Cosmecca Korea competitors include Procter & Gamble Health, T Hasegawa, Menicon, Mega Lifesciences, Safilo Group, Sarantis Group, ODDITY Tech, Synsam, Genomma Lab and Chicmax Cosmetic.

Most Cosmecca Korea public comparables operate across Health & Beauty.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Procter & Gamble Health$146M$49M6.1x6.1x18.3x18.7x
T Hasegawa$465M$94M1.5x1.4x7.2x6.7x
Menicon$795M$129M1.5x1.5x9.3x8.5x
Mega Lifesciences$423M$82M1.8x1.7x9.3x7.7x
Safilo Group$1.1B$123M0.8x0.8x6.8x6.2x
Sarantis Group$674M$101M1.2x1.1x7.9x7.5x
ODDITY Tech$810M$131M1.7x2.0x10.7x24.5x
Synsam$725M$129M1.5x1.4x8.3x5.8x

This data is available for Pro users. Sign up to see all Cosmecca Korea competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cosmecca Korea

When was Cosmecca Korea founded?Cosmecca Korea was founded in 1999.
Where is Cosmecca Korea headquartered?Cosmecca Korea is headquartered in South Korea.
How many employees does Cosmecca Korea have?As of today, Cosmecca Korea has over 450 employees.
Is Cosmecca Korea publicly listed?Yes, Cosmecca Korea is a public company listed on Korea Exchange.
What is the stock symbol of Cosmecca Korea?Cosmecca Korea trades under 241710 ticker.
When did Cosmecca Korea go public?Cosmecca Korea went public in 2016.
Who are competitors of Cosmecca Korea?Cosmecca Korea main competitors include Procter & Gamble Health, T Hasegawa, Menicon, Mega Lifesciences, Safilo Group, Sarantis Group, ODDITY Tech, Synsam, Genomma Lab, Chicmax Cosmetic.
What is the current market cap of Cosmecca Korea?Cosmecca Korea's current market cap is $903M.
What is the current revenue of Cosmecca Korea?Cosmecca Korea's last 12 months revenue is $598M.
What is the current revenue growth of Cosmecca Korea?Cosmecca Korea revenue growth (NTM/LTM) is 22%.
What is the current EV/Revenue multiple of Cosmecca Korea?Current revenue multiple of Cosmecca Korea is 1.8x.
What is the current EBITDA of Cosmecca Korea?Cosmecca Korea's last 12 months EBITDA is $95M.
What is Cosmecca Korea's EBITDA margin?Cosmecca Korea's last 12 months EBITDA margin is 16%.
What is the current EV/EBITDA multiple of Cosmecca Korea?Current EBITDA multiple of Cosmecca Korea is 11.1x.
What is the current FCF of Cosmecca Korea?Cosmecca Korea's last 12 months FCF is $33M.
What is Cosmecca Korea's FCF margin?Cosmecca Korea's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of Cosmecca Korea?Current FCF multiple of Cosmecca Korea is 31.6x.
How many companies Cosmecca Korea has acquired to date?Cosmecca Korea hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cosmecca Korea has invested to date?Cosmecca Korea hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Cosmecca Korea

Lists including Cosmecca Korea

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial